These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6786801)

  • 41. Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for mucopolysaccharidosis II (Hunter disease).
    Wang D; Wood T; Sadilek M; Scott CR; Turecek F; Gelb MH
    Clin Chem; 2007 Jan; 53(1):137-40. PubMed ID: 17082248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of the organisation of coding sequences within the iduronate sulphate sulphatase (IDS) gene.
    Flomen RH; Green EP; Green PM; Bentley DR; Giannelli F
    Hum Mol Genet; 1993 Jan; 2(1):5-10. PubMed ID: 8490623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prenatal diagnosis of the Hunter syndrome and the introduction of a new fluorimetric enzyme assay.
    Keulemans JL; Sinigerska I; Garritsen VH; Huijmans JG; Voznyi YV; van Diggelen OP; Kleijer WJ
    Prenat Diagn; 2002 Nov; 22(11):1016-21. PubMed ID: 12424767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers.
    Lin SP; Chang JH; Lee-Chen GJ; Lin DS; Lin HY; Chuang CK
    Clin Chim Acta; 2006 Jul; 369(1):29-34. PubMed ID: 16480701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA and enzyme studies on chorionic villi for use in antenatal diagnosis.
    Upadhyaya M; Archer IM; Harper PS; Jasani B; Roberts A; Shaw DJ; Thomas NS; Williams H
    Clin Chim Acta; 1984 Jun; 140(1):39-46. PubMed ID: 6430598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Iduronate sulfatase from human plasma.
    Wasteson A; Neufeld EF
    Methods Enzymol; 1982; 83():573-8. PubMed ID: 6954344
    [No Abstract]   [Full Text] [Related]  

  • 47. Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene.
    Hopwood JJ; Bunge S; Morris CP; Wilson PJ; Steglich C; Beck M; Schwinger E; Gal A
    Hum Mutat; 1993; 2(6):435-42. PubMed ID: 8111411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct assay of iduronate-2-sulfatase for Hunter disease using UPLC-tandem mass spectrometry and fluorogenic substrate.
    Lee K; Jun SH; Song SH; Park HD; Park KU; Song J
    Clin Biochem; 2015 Dec; 48(18):1350-3. PubMed ID: 26297117
    [TBL] [Abstract][Full Text] [Related]  

  • 49. X-linked Hunter syndrome: the heterozygous phenotype in cell culture.
    Migeon BR; Sprenkle JA; Liebaers I; Scott JF; Neufeld EF
    Am J Hum Genet; 1977 Sep; 29(5):448-54. PubMed ID: 409283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An assay for iduronate sulfatase (Hunter corrective factor).
    Lim TW; Leder IG; Bach G; Neufeld EF
    Carbohydr Res; 1974 Oct; 37(1):103-9. PubMed ID: 4214613
    [No Abstract]   [Full Text] [Related]  

  • 51. Hunter disease (mucopolysaccharidosis type II) in a karyotypically normal girl.
    Clarke JT; Willard HF; Teshima I; Chang PL; Skomorowski MA
    Clin Genet; 1990 May; 37(5):355-62. PubMed ID: 2112988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetics of Hunter syndrome: carrier detection, new mutations, segregation and linkage analysis.
    Chase DS; Morris AH; Ballabio A; Pepper S; Giannelli F; Adinolfi M
    Ann Hum Genet; 1986 Oct; 50(4):349-60. PubMed ID: 3126700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Production of polyclonal antibodies to protein iduronate-2-sulphate sulphatase (IDS) and development of a detection system for human recombinant IDS].
    Peña O; Sosa A; Echeverri O; Sáenz H; Barrera LA
    Biomedica; 2005 Jun; 25(2):181-8. PubMed ID: 16022372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hunter syndrome: case report and review of literature.
    Ogunbiyi A; Adeyinka AO; Ogah SO; Baiyeroju AM
    West Afr J Med; 2006; 25(2):169-72. PubMed ID: 16918195
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diagnosis of Hunter's disease. Enzyme study].
    Schiavulli E; Loffredo L; Vecchio L; Giugliano R; Carfagnini N; Carlomagno S
    Minerva Pediatr; 1977 Oct; 29(32):1937-46. PubMed ID: 413027
    [No Abstract]   [Full Text] [Related]  

  • 56. Feasibility of first trimester prenatal diagnosis of Hunter syndrome.
    Lykkelund C; Søndergaard F; Therkelsen AJ; Tønnesen T; Rasmussen V; Mikkelsen M; Güttler F; Nyland MH
    Lancet; 1983 Nov; 2(8359):1147. PubMed ID: 6138678
    [No Abstract]   [Full Text] [Related]  

  • 57. First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS).
    Alcalde-Martín C; Muro-Tudelilla JM; Cancho-Candela R; Gutiérrez-Solana LG; Pintos-Morell G; Martí-Herrero M; Munguira-Aguado P; Galán-Gómez E
    Eur J Med Genet; 2010; 53(6):371-7. PubMed ID: 20709629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First trimester diagnosis of Hunter syndrome on chorionic villi.
    Kleijer WJ; van Diggelen OP; Janse HC; Galjaard H; Dumez Y; Boué J
    Lancet; 1984 Aug; 2(8400):472. PubMed ID: 6147543
    [No Abstract]   [Full Text] [Related]  

  • 59. Hunter's disease in a girl: association with X:5 chromosomal translocation disrupting the Hunter gene.
    Mossman J; Blunt S; Stephens R; Jones EE; Pembrey M
    Arch Dis Child; 1983 Nov; 58(11):911-5. PubMed ID: 6418082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reassessment of biochemically determined Hunter syndrome carrier status by DNA testing.
    Timms KM; Edwards FJ; Belmont JW; Yates JR; Gibbs RA
    J Med Genet; 1998 Aug; 35(8):646-9. PubMed ID: 9719370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.